GINGER WEBB: Open Payments
NPI 1770990061 · PIKEVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$963 in 49 payments from 18 companies in 2025. Trend: 2023 $2,226 · 2024 $1,936 · 2025 $963
Food & beverage: $918Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $275 |
| PFIZER INC. | 4 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $75 |
| GlaxoSmithKline, LLC. | 3 | $70 |
| Lilly USA, LLC | 2 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Grifols USA, LLC | 2 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| Novo Nordisk Inc | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
Products named: VRAYLAR, NURTEC ODT, QULIPTA, Kerendia, TRELEGY ELLIPTA, UBRELVY, TRINTELLIX, Prolastin-C Liquid.
Industry payments across KY — which companies pay providers there.
